Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2002
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP1246619A1 Urotensin-ii receptor antagonists
10/09/2002EP1246538A1 Thickened oil compositions of edible oil
10/09/2002EP1049467B1 Celecoxib compositions
10/09/2002EP0973550B1 Antagonistic anti-avb3 integrin antibodies
10/09/2002EP0967986B1 USE OF HUMAN alpha 1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION
10/09/2002EP0964856B1 Bicyclic amino acids
10/09/2002EP0946542B1 Indane or dihydroindole derivatives
10/09/2002EP0853477B1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
10/09/2002EP0683774B1 Hypolipidaemic compounds
10/09/2002CN1373774A Compositions isolated from skin cells and methods for their use
10/09/2002CN1373763A Pteridinones and kinase inhibitors
10/09/2002CN1373757A Heterocyclically substd, benzoylguanidine, method for production thereof, use thereof as medicament or means of diagnosis and medicaments contg. same
10/09/2002CN1373755A Azacycloalkanone serine protease inhibitors
10/09/2002CN1373753A Mutual salt of amlodipine and atorvastatin
10/09/2002CN1373752A Prostaglandin derivs.
10/09/2002CN1373750A 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
10/09/2002CN1373745A 3-amino-2-benzyl-1-phenyl-propane derivs.
10/09/2002CN1373666A Medicament with protective effect against oxidative-toxic substances, particularly against cardiotoxin substances
10/09/2002CN1373665A Pharmaceutical solutions for levosimendan
10/09/2002CN1373663A Use of 2-imidazolyl substd, carbinols for production of medicament for treatment or prophylaxis of disease states as result of ischaemic conditions
10/09/2002CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002CN1373217A Cell multiplication factor Fwap10576
10/09/2002CN1373216A Muscle cell multiplication suppressor factor Fwa267
10/09/2002CN1373208A Variant strain of monoscus purpureus for generating lovastatin with high yield and its application
10/09/2002CN1373127A Crystal choline ascorbate
10/09/2002CN1372964A Granular medicine 'Yandan' and its preparing process
10/09/2002CN1372960A Medicine for treating hypertension and its preparing process
10/09/2002CN1372948A Exterior-applied liquid medicine for promoting blood circulation, dispelling exogenous factor of wind and relaxing pain
10/09/2002CN1372945A Magnetotherapeutic medicinal pad and its preparing process
10/09/2002CN1372940A Chinese medicine for treating cerebral haemorrhage
10/09/2002CN1372934A Application of N-acetyl-D-aminoglucose in preparing medicines to treat cardiac and cerebral ischemia and anoxia
10/09/2002CN1372928A Application of ketanserin in improving myocardial infarction prognosis
10/09/2002CN1092203C Process for extracting ginsenoside Re, and use of medicine thereof
10/09/2002CN1092202C Substd. aminoalkane phosphonic acids
10/09/2002CN1092049C Composition for treating late allergic reactions and inflammation diseases, and use thereof
10/09/2002CN1092030C Method for extracting sulfur-contg. component part from galic and method for preparation of oil and fat contg. same
10/08/2002US6462211 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
10/08/2002US6462091 A tertiary amine substituted with a monochlorinated diphenyl-ether, a phenylperfluoroethyl ether and a hydroxylated fluorinated alkane; synergistic with mevastatin, lovastatin, simvastatin, pravastatin, fluvastatin or atorvastatin
10/08/2002US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors
10/08/2002US6462074 Substituted α, β-anellated butyrolactones
10/08/2002US6462068 Heterocyclylmethyl-substituted pyrazole derivatives
10/08/2002US6462067 Administering histamine or salt derivative; preventing and/or reducing oxidative cellular and tissue damage; inflammatory diseases, including rheumatoid arthritis, crohn's disease, and adult respiratory distress syndrome
10/08/2002US6462066 Method and composition for treatment of ischemic neuronal reperfusion injury
10/08/2002US6462060 Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/08/2002US6462057 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
10/08/2002US6462048 3-(2-(4-methylpiperazin-1-yl)-benzylidene)-1,3-dihydro-indol-2-one for example; useful as psychotherapeutic agents
10/08/2002US6462047 Containing 5- or 6-membered oxygen, nitrogen and/or sulfur heteroaryl group; angina, hypertension, respiratory distress, congestive heart failure, renal failure, atherosclerosis, inflammatory diseases, strokes, bronchitis, asthma
10/08/2002US6462045 Method of treating pulmonary hypertension
10/08/2002US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002US6462035 Binding to neuronal nicotinic acetylcholine specific receptor; modulating cholinergic function; reducing nicotine addiction; inflammatory and irritable bowel syndrome, spastic dystonia, chronic and acute pain, eating disorders
10/08/2002US6462024 Use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substrates of the heart
10/08/2002US6462022 Lisinopril compositions having large-particle DCPD
10/08/2002US6462021 Melagatran or derivative; nonvalvular atrial fibrillation; thrombotic or ischemic stroke, transient ischemic attack or systemic embolism
10/08/2002US6461855 Microtubule stimulated atpase activity; cancer and nervous system disorder diagnosis
10/08/2002US6461846 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects
10/08/2002US6461822 Therapeutic targets for agents that suppress the release of inflammatory mediators such as interleukin il-1 and il-1 beta
10/08/2002US6461648 Solvent extraction of berries
10/08/2002US6461625 Nanoemulsion based on alkoxylated alkenyl succinates or alkoxylated alkenyl succinates of glucose and its uses in the cosmetics, dermatological, opthalmological and/or pharmaceutical fields
10/08/2002US6461613 Methods and compositions for the selective regulation of chorionic prostanoids
10/08/2002US6461602 Water-soluble, nontoxic prodrugs having a hydrolyzable carbamate group coupling the drug or active ingredient to a modified polymer; insoluble drug released in vivo; drug delivery
10/08/2002CA2231046C Human protein kinases hyak3
10/08/2002CA2196769C Benzimidazole derivatives having dopaminergic activity
10/08/2002CA2172354C Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them
10/08/2002CA2084489C Crystalline fumaric acid salts of 9,9-alkylene-3, 7-diazabicyclononane compounds and pharmaceutical compositions containing them
10/07/2002WO2001076598A1 Stabilized pharmaceutical compositions containing calcium channel blockers
10/06/2002CA2378565A1 Crystal structure
10/04/2002CA2342708A1 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
10/03/2002WO2002077266A2 Novel fibroblast growth factor and nucleic acids encoding same
10/03/2002WO2002077263A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002WO2002077216A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/03/2002WO2002077017A2 Medical uses of intercellular communication facilitating compounds
10/03/2002WO2002077003A1 Process for obtaining lignan, pharmaceutical compositions and uses thereof
10/03/2002WO2002076995A2 2-amino-propanol derivatives
10/03/2002WO2002076986A1 Pyrazolopyrimidines as therapeutic agents
10/03/2002WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002WO2002076977A2 Rho-kinase inhibitors
10/03/2002WO2002076976A2 Rho-kinase inhibitors
10/03/2002WO2002076973A1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient
10/03/2002WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002WO2002076963A1 Bicyclic guanidine derivatives and therapeutic uses thereof
10/03/2002WO2002076957A1 Activator for peroxisome proliferator-activated receptor
10/03/2002WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002WO2002076949A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
10/03/2002WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors
10/03/2002WO2002076947A1 Mch antagonists and their use in the treatment of obesity
10/03/2002WO2002076946A2 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
10/03/2002WO2002076945A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002WO2002076939A2 Cysteine protease inhibitors
10/03/2002WO2002076933A1 Formailide derivatives as beta2-adrenoreceptor agonists
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076509A2 Preparation for the prophylaxis of restenosis
10/03/2002WO2002076486A2 Histidine-rich glycoprotein
10/03/2002WO2002076482A2 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS
10/03/2002WO2002076476A2 Prodrugs of anticancer agents employing substituted aromatic acids
10/03/2002WO2002076460A2 Use of propentofylline to control intraocular pressure
10/03/2002WO2002076455A1 Autonomic controlling agents and health drinks and foods
10/03/2002WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
1 ... 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 ... 1595